Ancor, Sentinel exit final Wellspring unit in trade sale to ANI Pharmaceuticals

Sentinel Capital Partners and Ancor Capital Partners have sold the final part of their Wellspring investment by parting with its contract drug manufacturing business to ANI Pharmaceuticals.